Skip to main content
Clinical Trials/NCT01894841
NCT01894841
Completed
N/A

Veterans Coping Long-Term With Suicide

VA Office of Research and Development1 site in 1 country107 target enrollmentFebruary 24, 2014
ConditionsSuicide

Overview

Phase
N/A
Intervention
Not specified
Conditions
Suicide
Sponsor
VA Office of Research and Development
Enrollment
107
Locations
1
Primary Endpoint
Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an innovative, telephone-based intervention that combines elements of individual therapy, case management, and significant other/family therapy and is designed to be integrated into a VA system.

Detailed Description

Suicide is a leading cause of death for military personnel, and for the first time in recorded history, rates of military suicides are exceeding civilian rates. Despite public and patient health costs associated with suicidal ideation and behavior, existing efforts haven't appreciably reduced rates of suicidal behavior in the military. Consequently, finding novel, efficacious, and acceptable methods to reduce suicide behaviors is imperative. The Veteran's Coping Long Term with Active Suicide Program (CLASP-VA) is a unique suicide reduction intervention that directly targets high-risk patients at the time of hospital discharge. It is one of the few empirically-developed and promising interventions (e.g., strong pilot data) for individuals hospitalized for suicide behavior. The primary objective of this study is to test the efficacy of the CLASP intervention compared to a treatment as usual plus Safety Assessment and Follow-up Evaluation (SAFE) control condition. Efficacy will be determined by primary outcomes including: number of attempts, number of re-hospitalizations, severity, and chronicity of suicidal ideation. A secondary objective is identifying the types of patients who receive the most benefit from the CLASP-VA intervention.

Registry
clinicaltrials.gov
Start Date
February 24, 2014
End Date
August 29, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a suicide attempt within 1 week of hospitalization
  • age greater than 18
  • have a telephone
  • ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study

Exclusion Criteria

  • long-term psychiatric disorder
  • diagnosis of borderline personality disorder
  • cognitive impairment which would interfere with adequate participation in the project (MMSE \<20)

Outcomes

Primary Outcomes

Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior

Time Frame: baseline, 3, 6, 9, & 12 month post-hospitalization

Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior. We log transformed this variable at all time points to meet assumptions of normality.

Secondary Outcomes

  • Brief Symptom Inventory(Baseline, 3, 6, 9, & 12 month follow up)
  • Changes in Beck Hopelessness Scale(Baseline, 3, 6, 9, & 12 month follow up)
  • World Health Organization Disability Assessment Schedule (WHODAS) II(Baseline, 3, 6, 9, & 12 month follow ups)
  • Treatment History Interview(3, 6, 9, & 12 month follow up)
  • Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity(baseline, 3, 6, 9, & 12 month post-hospitalization)

Study Sites (1)

Loading locations...

Similar Trials